These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12163084)

  • 1. Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound.
    Yamani MH; Tuzcu EM; Starling RC; Young JB; Cook DJ; Haji SA; Abdo A; Crowe T; Hobbs R; Rincon G; Bott-Silverman C; McCarthy PM; Ratliff NB
    J Heart Lung Transplant; 2002 Aug; 21(8):850-9. PubMed ID: 12163084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular rejection and rate of progression of transplant vasculopathy: a 3-year serial intravascular ultrasound study.
    Jimenez J; Kapadia SR; Yamani MH; Platt L; Hobbs RE; Rincon G; Botts-Silverman C; Starling RC; Young JB; Nissen SE; Tuzcu M; Ratliff NB
    J Heart Lung Transplant; 2001 Apr; 20(4):393-8. PubMed ID: 11295576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does acute cellular rejection correlate with cardiac allograft vasculopathy?
    Yamani MH; Yousufuddin M; Starling RC; Tuzcu M; Ratliff NB; Cook DJ; Abdo A; Crowe T; Hobbs R; Rincon G; Bott-Silverman C; McCarthy PM; Young JB
    J Heart Lung Transplant; 2004 Mar; 23(3):272-6. PubMed ID: 15019635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial ischemic-fibrotic injury after human heart transplantation is associated with increased progression of vasculopathy, decreased cellular rejection and poor long-term outcome.
    Yamani MH; Haji SA; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Crowe T; Secic M; McCarthy P; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(6):970-7. PubMed ID: 11897438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.
    Mehra MR; Ventura HO; Jain SP; Ramireddy K; Ali A; Stapleton DD; Smart FW; Ramee SR; Collins TJ; White CJ
    J Am Coll Cardiol; 1997 May; 29(6):1339-44. PubMed ID: 9137233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular abnormalities and cardiomyocyte lipofuscin deposits in endomyocardial biopsy specimens of heart transplant recipients: are they related to the development of cardiac allograft vasculopathy?
    Zakliczynski M; Nozynski J; Konecka-Mrowka D; Krynicka-Mazurek A; Swierad M; Maruszewski M; Przybylski R; Zembala M
    J Thorac Cardiovasc Surg; 2009 Jul; 138(1):215-21, 221.e1-3. PubMed ID: 19577082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quilty lesions are associated with increased expression of vitronectin receptor (alphavbeta3) and subsequent development of coronary vasculopathy.
    Yamani MH; Ratliff NB; Starling RC; Tuzcu EM; Yu Y; Cook DJ; Crow T; Hobbs R; Rincon G; Bott-Silverman C; McCarthy PM; Young JB
    J Heart Lung Transplant; 2003 Jun; 22(6):687-90. PubMed ID: 12821166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of combined Angiotensin-converting enzyme inhibition and calcium antagonism on allograft coronary vasculopathy validated by intravascular ultrasound.
    Erinc K; Yamani MH; Starling RC; Crowe T; Hobbs R; Bott-Silverman C; Rincon G; Young JB; Feng J; Cook DJ; Smedira N; Tuzcu EM
    J Heart Lung Transplant; 2005 Aug; 24(8):1033-8. PubMed ID: 16102438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus infection and accelerated cardiac allograft vasculopathy in human cardiac allografts.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    J Heart Lung Transplant; 1993; 12(5):724-9. PubMed ID: 8241209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation.
    Yousufuddin M; Haji S; Starling RC; Tuzcu EM; Ratliff NB; Cook DJ; Abdo A; Saad Y; Karnik SS; Wang D; McCarthy PM; Young JB; Yamani MH
    Eur Heart J; 2004 Mar; 25(5):377-85. PubMed ID: 15033249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of vitronectin receptor (alphavbeta3) and tissue factor in the pathogenesis of transplant coronary vasculopathy.
    Yamani MH; Masri CS; Ratliff NB; Bond M; Starling RC; Tuzcu EM; McCarthy PM; Young JB
    J Am Coll Cardiol; 2002 Mar; 39(5):804-10. PubMed ID: 11869845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary endothelial dysfunction as a predictor of intimal thickening in the long term after heart transplantation.
    Martí V; Romeo I; Aymat R; García J; Guiteras P; Ballester M; Aminian N; Caralps JM; Augé JM
    J Thorac Cardiovasc Surg; 2001 Dec; 122(6):1174-80. PubMed ID: 11726893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variability of transplant vasculopathy. A study with intravascular ultrasound].
    Klauss V; Rieber J; Uberfuhr P; Theisen K; Mudra H
    Z Kardiol; 1995 Feb; 84(2):121-9. PubMed ID: 7717015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of donor and recipient gender on cardiac allograft vasculopathy. An intravascular ultrasound study.
    Mehra MR; Stapleton DD; Ventura HO; Escobar A; Cassidy CA; Smart FW; Collins TJ; Ramee SR; White CJ
    Circulation; 1994 Nov; 90(5 Pt 2):II78-82. PubMed ID: 7955289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytomegalovirus infection accelerates cardiac allograft vasculopathy: correlation between angiographic and endomyocardial biopsy findings in heart transplant patients.
    Koskinen PK; Nieminen MS; Krogerus LA; Lemström KB; Mattila SP; Häyry PJ; Lautenschlager IT
    Transpl Int; 1993; 6(6):341-7. PubMed ID: 8297464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities in intramyocardial arteries detected in cardiac transplant biopsy specimens and lack of correlation with abnormal intracoronary ultrasound or endothelial dysfunction in large epicardial coronary arteries.
    Clausell N; Butany J; Molossi S; Lonn E; Gladstone P; Rabinovitch M; Daly PA
    J Am Coll Cardiol; 1995 Jul; 26(1):110-9. PubMed ID: 7541058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity-quality paradox.
    Mehra MR; Ventura HO; Uber PA; Scott RL; Park MH
    J Heart Lung Transplant; 2003 Feb; 22(2):118-23. PubMed ID: 12581758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.